Research in social & administrative pharmacy : RSAP
-
Res Social Adm Pharm · Aug 2019
Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis.
Effective communication between prescribers of opioids and community pharmacists can contribute to maximizing appropriate pain management and reducing opioid misuse and diversion. While much of the education and training available on reducing opioid misuse and diversion stresses the importance of interprofessional communication between prescribers and pharmacists, few studies have been explored those communication patterns directly. ⋯ Physician and pharmacist communication around opioids can be mutually beneficial. When prescribers and pharmacists are co-located, higher levels of trust and teamwork are reported, which in turn seems to be related to more open and positive communication. Additional research is needed to identify interventions to increase mutually-valued communication that improves the quality of decision-making around opioids.
-
Res Social Adm Pharm · Aug 2019
How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
and Aims: Opioid overdose can be reversed with timely administration of naloxone. In Australia, naloxone was rescheduled from prescription only (S4) to pharmacist only over-the-counter (OTC, S3) in February 2016, increasing access for the general public. A key barrier to naloxone supply by pharmacists is a lack of knowledge, highlighting the role of pharmacist education. Community pharmacists' education, experience, and training preferences related to naloxone provision, overdose, and substance use disorder were examined. ⋯ Most community pharmacists in Australia are willing to attend training on providing naloxone and preventing opioid overdose. There are opportunities to develop and expand the online presence of training, guidelines, and education materials to facilitate the expanded supply of OTC naloxone.
-
Res Social Adm Pharm · Aug 2019
Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
Pharmacists have played an increasingly critical role in combatting the epidemic of prescription opioid misuse and abuse, due in large part to their accessibility and their function as gatekeepers to prescription medication. Throughout the United States, pharmacists have crafted interventions designed to prevent, identify, and manage opioid misuse and abuse. In order to be effective, however, both patients and pharmacists must comply with interventions. To ensure compliance with proposed pharmacy-based interventions, both patients and pharmacists must recognize patient education, screening and counseling for substance misuse and abuse as acceptable components of pharmacy practice.
-
Res Social Adm Pharm · Aug 2019
Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse.
Opioid misuse causes over 50,000 deaths in America each year. Prescription drug monitoring program (PDMP) databases serve as a useful decision analysis tool in managing patients with known or potential opioid use disorder (OUD). To date, however, little research has sought to determine how pharmacists use PDMPs to engage patients with potential OUD. ⋯ The results illustrate some of the challenges faced by community pharmacists when considering engagement of patients with misuse of prescription opioids. Addressing these barriers to patient engagement is critical to increasing pharmacists' willingness to engage patients with potential OUD.
-
Res Social Adm Pharm · Aug 2019
Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
Increases in opioid use and related harms such as mortality are occurring in many high income countries. Community pharmacists are often in contact with patients at risk of opioid-related harm and represent an ideal point for intervention. Best practice in monitoring opioid-related outcomes involves assessing analgesia, pain functioning, mood, risks and harms associated with opioid use. Community pharmacists are well-placed to undertake these tasks. ⋯ Our study will examine changes in pharmacists' knowledge and confidence to deliver the SBI. Through the implementation pilot, we will establish the feasibility and acceptability of a pharmacist SBI that aims to improve monitoring and clinical management of patients who are prescribed opioids.